Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings
NCT ID: NCT01264185
Last Updated: 2022-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
751 participants
OBSERVATIONAL
2010-04-30
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings
NCT01256463
HIV Prevention in Very High Risk Men Who Have Sex With Men
NCT01291589
Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
NCT01152918
Behavioral Intervention to Enhance HIV Test/Treat
NCT01752777
HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission
NCT02044484
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Asia--Thailand; S. America--Brazil
No interventions assigned to this group
Africa--Zambia
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Documented evidence of HIV infection (HIV diagnosis performed outside of the trial is acceptable so long as local/country guidelines were followed in the testing)
* Receiving HIV/AIDS care (defined as at least two visits within 9 months of enrollment) in a formal health care setting (clinic or hospital)
* Reported history of sexual risk behavior in the previous 12 months, including: acquisition of a sexually transmitted infection, vaginal or anal intercourse without a condom, difficulty negotiating condom use, or non-disclosure of HIV status to an HIV-uninfected partner or partner of unknown HIV serostatus.
* NOTE: For the MSM population, we will enroll men who have sex with men, regardless of whether or not they also have sex with women
Exclusion Criteria
* Anyone having unprotected (i.e. without a condom) sex for the expressed purpose of conceiving
* Planning to relocate out of the area in the next year
* Any condition that, in the opinion of the Investigator of Record or designee, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HIV Prevention Trials Network
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Steve Safren, PhD
Role: STUDY_CHAIR
Fenway Community Health Center
Ken Mayer, MD
Role: STUDY_CHAIR
Fenway Community Health Center
Stewart Reid, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Centre for Infectious Disease Research in Zambia (CIDRZ)
Ruth Friedman, MD
Role: PRINCIPAL_INVESTIGATOR
Instituto de Pesquisa Clincia Evandro Chagas (IPEC) Clinical Research Site (CRS)
Kriengkrai Srithanaviboonchai, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
Chiang Mai University AIDS CRS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Instituto de Pesquisa Clinicaq Evandro Chagas CRS
Manguinhos, Rio de Janeiro, Brazil
Chiang Mai University AIDS CRS
Chiang Mai, , Thailand
Matero Reference Clinic
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPTN 063
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.